美国 · 平台与数据 · Yahoo Finance

Is Krystal Biotech (KRYS) Undervalued On Earnings, Buybacks, And Vyjuvek Growth?

来源：Yahoo Finance · 美国 12 小时前

Krystal Biotech (KRYS) just paired a third quarter earnings beat with a new US$400 million share repurchase plan, giving investors fresh numbers on Vyjuvek demand and updated…

在 Yahoo Finance 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)

Is Krystal Biotech (KRYS) Undervalued On Earnings, Buybacks, And Vyjuvek Growth?

推荐阅读

Fabrinet (FN) Q1 2027 Earnings Call Transcript

Angel Oak Financial Strategies Income Term declares $0.115 dividend

Adani Group seeks $1.5 bln loan for data center expansion- Economic Times

Stock market after midterm elections: What S&P 500 history shows

Amundi Funds - Income Opportunities A70 SGD MTD2 D

S&P 500, Nasdaq Drop As Capex Concerns Grip Tech Investors, Outweighing US-Iran Diplomacy Hope — ORCL, META, PLTR, AAPL In Focus

Is Krystal Biotech (KRYS) Undervalued On Earnings, Buybacks, And Vyjuvek Growth?

分享

推荐阅读

Fabrinet (FN) Q1 2027 Earnings Call Transcript

Angel Oak Financial Strategies Income Term declares $0.115 dividend

Adani Group seeks $1.5 bln loan for data center expansion- Economic Times

Stock market after midterm elections: What S&P 500 history shows

Amundi Funds - Income Opportunities A70 SGD MTD2 D

S&P 500, Nasdaq Drop As Capex Concerns Grip Tech Investors, Outweighing US-Iran Diplomacy Hope — ORCL, META, PLTR, AAPL In Focus